Le Lézard
Classified in: Health
Subject: AWD

Heartland Dental CEO Patrick Bauer Recognized as a Glassdoor Top CEO in 2019


EFFINGHAM, Ill., June 19, 2019 /PRNewswire/ -- Heartland Dental CEO, Patrick Bauer has won a Glassdoor Employees' Choice Award honoring the Top CEOs in 2019. Glassdoor, one of the world's largest job and recruiting sites, released its annual award recognizing the Top CEOs, which highlights top leaders that employees love working for in countries throughout North America and parts of Europe.

(PRNewsfoto/Heartland Dental)

Among the 900,000 companies and chief executives reviewed on Glassdoor, Bauer has an impressive approval rating of 92 percent (average Glassdoor approval rating is 69 percent). This rating is based on the anonymous and voluntary reviews Heartland Dental employees shared on Glassdoor throughout the past year. In addition to being a CEO award, this is a great achievement for Heartland Dental as a company. More and more supported dentists and team members have continued to share their experiences and feedback, contributing to Heartland Dental's excellent company rating on Glassdoor and making this recognition possible.

"It's an honor and pleasure to receive this recognition in the company of so many other amazing, innovative leaders," said Bauer. "Our supported dentists and team members are the lifeblood of our company, and the reason we exist. It's our goal to create the best environment possible for everyone at Heartland Dental. I'm excited to see that so many have shared their great experiences."

When employees submit reviews about their company on Glassdoor, they are asked to rate various factors about their employment experience, including their overall satisfaction and other workplace attributes like senior management. As part of these ratings, employees are also asked to rate whether they approve, disapprove or are neutral about the job their CEO is doing. Glassdoor's Top CEOs in 2019 were determined using company reviews shared by U.S.-based employees between May 2nd, 2018 and May 1st, 2019.  

For the complete list of all Glassdoor Top CEOs winners in 2019, please visit: https://www.glassdoor.com/Award/Top-CEOs-LST_KQ0,8.htm

To learn more about Heartland Dental, click here.

Media Contact:
Adam Lueken, Corporate Communications
(217) 540-5664 or [email protected]

 

SOURCE Heartland Dental


These press releases may also interest you

at 07:05
Executive War College to Address, Clinical Laboratories' and Genetic Testing Firms' Perfect Storm, involving FDA's Proposed LDT Rule, Payers Requiring Z-Codes on Genetic Test Claims, and Revisions to CLIA Regulations
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Health Canada Approves KEYTRUDA® as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma in combination with fluoropyrimidine- and platinum-containing chemotherapy
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
GLOBE LIFE INC. ANNOUNCES FIRST QUARTER 2024 EARNINGS RELEASE AND CONFERENCE CALL
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
Drug-Free Pain Relief Comes in the Form of Red Laser Therapy
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...

More news about Health...


News published on and distributed by: